Evidence map›Paper›PMID 33884178›Full record

ArticleToxicology research2021

Sodium arsenite induces spatial learning and memory impairment associated with oxidative stress and activates the Nrf2/PPARγ pathway against oxidative injury in mice hippocampus.

Liang Xiong, Jinyu Huang, Ying Gao, Yanfang Gao, Chunmei Wu, Shengfa He, Lijun Zou, Dongmei Yang, Yuhao Han, Qiong Yuan and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Toxicology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Liang XiongKey Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Number 1 Yixueyuan Road, Ganzhou 341000, China.ORCID 0000-0002-7717-2463
Jinyu HuangKey Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Number 1 Yixueyuan Road, Ganzhou 341000, China.
Ying GaoDepartment of rehabilitation medicine, School of Rehabilitation, Gannan Medical University, Number 1 Yixueyuan Road, Ganzhou 341000, Jiangxi, China.
Yanfang GaoKey Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Number 1 Yixueyuan Road, Ganzhou 341000, China.
Chunmei WuKey Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Number 1 Yixueyuan Road, Ganzhou 341000, China.
Shengfa HeSchool of Public Health and Health Management, Gannan Medical University, Number 1 Yixueyuan Road, Ganzhou 341000, Jiangxi, China.
Lijun ZouSchool of Public Health and Health Management, Gannan Medical University, Number 1 Yixueyuan Road, Ganzhou 341000, Jiangxi, China.
Dongmei YangSchool of Public Health and Health Management, Gannan Medical University, Number 1 Yixueyuan Road, Ganzhou 341000, Jiangxi, China.
Yuhao HanSchool of Public Health and Health Management, Gannan Medical University, Number 1 Yixueyuan Road, Ganzhou 341000, Jiangxi, China.
Qiong YuanSchool of Public Health and Health Management, Gannan Medical University, Number 1 Yixueyuan Road, Ganzhou 341000, Jiangxi, China.
Zuobing ZhengKey Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Number 1 Yixueyuan Road, Ganzhou 341000, China.
Gonghua HuKey Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Number 1 Yixueyuan Road, Ganzhou 341000, China.
Gannan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arsenic (As) is a ubiquitous environmental and industrial toxin with known correlates of oxidative stress and cognitive deficits in the brain. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcriptional factor that represents a central cellular antioxidant defense mechanism and transcribes many antioxidant genes. Peroxisome proliferator-activated receptor-gamma (PPARγ) is a well-known nuclear receptor to regulate lipid metabolism in many tissues, and it has been also associated with the control of oxidative stress, neuronal death, neurogenesis and differentiation. The role of Nrf2 and PPARγ in As-induced neurotoxicity is still debated. The present study was designed to investigate the neurobehavioral toxic effect of sub-chronic and middle-dose sodium arsenite exposure in mice hippocampus, as well as the response of Nrf2/PPARγ expression and influence on protein expression levels of their downstream antioxidant genes. Our results showed that mice treated with intraperitoneal injection of sodium arsenite (50 mg/kg body wt.) twice a week for 7 weeks resulted in increased generation of reactive oxygen species and impairment of spatial cognitive function. The present study also found a positive association between Nrf2/PPARγ expression in hippocampus of mice, and activation of antioxidant defenses by the evidently upregulated expression of their downstream genes, including superoxide dismutase, heme oxygenase-1 and glutathione peroxidase-3. Therefore, our findings were helpful for further understanding the role of Nrf2/PPARγ feedback loop in As-induced neurobehavioral toxicity.

Indexed as

arsenicneurobehavioral alterationsNrf2oxidative stressPPARγ

Identifiers

PMID33884178
PMCPMC8045596
OpenAlexW3132341313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.